Stay updated on Tisagenlecleucel in HR B-ALL Clinical Trial
Sign up to get notified when there's something new on the Tisagenlecleucel in HR B-ALL Clinical Trial page.

Latest updates to the Tisagenlecleucel in HR B-ALL Clinical Trial page
- CheckyesterdayNo Change Detected
- Check7 days agoChange DetectedPublications text updated to indicate PubMed publications are automatically filled; page revision label updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check15 days agoChange DetectedDeletion of a government funding/operating status notice from the page; the study details remain unchanged.SummaryDifference0.3%

- Check37 days agoChange DetectedNew study locations were added (Hackensack Uni Medical Center; Esplugues, Barcelona, Spain, 08950) and an existing site name was updated from Hackensack University Medical Center / Esplugues de Llobregat, Barcelona, Spain to Esplugues, Barcelona, Spain, 08950.SummaryDifference0.5%

- Check58 days agoChange DetectedUpdate includes a critical operating-status notice and an upgraded version identifier to v3.2.0, replacing the previous v3.1.0.SummaryDifference2%

- Check66 days agoChange DetectedMajor update to medical topic taxonomy: replaces broader leukemia/hematology terms with specific lymphoma and virus-related infections, and updates the revision version to v3.1.0.SummaryDifference2%

- Check73 days agoChange DetectedCore location details and update timing have been expanded and reformatted (e.g., fuller postal address and added estimated update label).SummaryDifference0.3%

Stay in the know with updates to Tisagenlecleucel in HR B-ALL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tisagenlecleucel in HR B-ALL Clinical Trial page.